Hunter Street Eye Specialists Optometry Educational Seminar 2024
Date: 26/03/2024 (AEDT)
Venue: 2 Macquarie Street, Parramatta, NSW, 2150
Provider: Hunter Street Eye Specialists
Contact: Michelle De Guia, [E] michelle@huntereye.com.au, [P] 02 9635 0663
Activity Outline
The Optometry education event will feature a diverse range of topics presented by experts in the field of Ophthalmology & Optometry. Each session is structured with clear learning objectives to guide participants' understanding and application of the presented material.
Dr Peter Sumich will discuss the relevance of Multifocal IOLs and Monovision in light of emerging Extended Depth of Focus (EDOF) technologies, questioning whether they can coexist or if one should phase out the other. The discussion on multifocal IOLs, Monovision, and EDOF technology aimed to familiarise attendees with emerging EDOF technologies, optimal applications of monovision, and the roles of optometrists in patient management.
Dr Ridia Lim will delve into non-IOP glaucoma risk factors and management, emphasizing evidence-based approaches to supplement traditional intraocular pressure considerations. Exploring non-IOP glaucoma risk factors and management, participants will delve into the potential benefits of supplements for glaucoma patients, factors to avoid, and lifestyle considerations
Dry Eye Management will be the core of Dr Diana Farlow’s presentation, offering insights into upcoming developments in 2024. Attendees gained the ability to distinguish between various dry eye syndromes, assess tear film quality, choose appropriate diagnostic tests, and tailor treatment strategies accordingly. Differentiation of dry eye syndromes, tear film assessment, appropriate use of diagnostic tests, and knowledge of treatment modalities.
Our Guest speaker Astha Rai, will address the issue of combating the myopia epidemic, exploring effective strategies, potential pitfalls, and innovative solutions. Highlighting the importance of outdoor activities in reducing myopia risk, along with advancements in innovative optical solutions. Additionally, emphasise promoting visual hygiene and staying updated on cutting-edge research and treatments.
Learning Objectives
- At the completion of the meeting, participants will be able to differentiate between dry eye syndromes
- At the completion of the meeting, participants will be able to assess and describe a patient’s tear film
- At the completion of the meeting, participants will know which dry eye tests are appropriate
- At the completion of the meeting, participants will have the knowledge to treat different types of dry eye syndromes
- At the completion of the meeting, participants will learn about emerging EDOF technologies
- At the completion of the meeting, participants will learn where to apply monovision
- At the completion of the meeting, participants will understand roles for Optometrists in patient management
- At the completion of the meeting, participants will learn “Should your glaucoma patients take supplements?”
- At the completion of the meeting, participants will learn What should be avoided in glaucoma management?
- At the completion of the meeting, participants will learn What lifestyle factors are important in glaucoma?
- At the completion of the meeting participants will be able to articulate evidence based treatment modalities including HALT spectacle lenses, dual focus soft contact lenses, orthokeratology and low dose atropine.
- At the completion of the meeting participants will be able to Understand the difference between subjective and objective methods of monitoring myopia control treatment efficacy.
- At the completion of the meeting participants will be able to Learn from myopia control case studies in clinical practice.
Max CPD hours awarded: 3
Session Information
Name |
---|
Multifocal IOLs, Monovision and EDOF. Only 2 can survive |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
0.5 |
Duration of CPD Session/Module inclusive of Assessment Component |
0.75 |
Name |
---|
Dry Eye Management: What’s Coming in 2024 |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
Yes |
Duration of CPD Session/Module |
0.5 |
Duration of CPD Session/Module inclusive of Assessment Component |
0.75 |
Name |
---|
Non-IOP glaucoma risk factors & management: What is the evidence? |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
Yes |
Duration of CPD Session/Module |
0.5 |
Duration of CPD Session/Module inclusive of Assessment Component |
0.75 |
Name |
---|
Combating the myopia epidemic: Effective Strategies, Pitfalls, and Innovations |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
Yes |
Duration of CPD Session/Module |
0.5 |
Duration of CPD Session/Module inclusive of Assessment Component |
0.75 |